Towards antibodies against COVID-19

The lab of Xavier Saelens (VIB-UGent Center for Medical Biotechnology) announces the isolation and characterization of a unique antibody that can bind to the virus that causes COVID-19 (SARS-CoV-2). The antibody was described in collaboration with research groups in the US. The team has established that the antibody binds to a conserved epitope on the spike protein of SARS-CoV-2. Read more